Cargando…
The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive tumors which originate from Schwann cells and develop in about 10% of neurofibromatosis type 1 (NF1) patients. The five year survival rate is poor and more effective therapies are needed. Sunitinib is a drug targeting...
Autores principales: | Zietsch, Jan, Ziegenhagen, Nicolas, Heppner, Frank L., Reuss, David, von Deimling, Andreas, Holtkamp, Nikola |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912277/ https://www.ncbi.nlm.nih.gov/pubmed/20686603 http://dx.doi.org/10.1371/journal.pone.0011858 |
Ejemplares similares
-
Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours
por: Bradtmöller, Maren, et al.
Publicado: (2012) -
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013) -
Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS
por: Reuss, David E., et al.
Publicado: (2013) -
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis
por: Magallón-Lorenz, Miriam, et al.
Publicado: (2023) -
Malignant Peripheral Nerve Sheath Tumour of the Maxilla
por: Sahai, Puja, et al.
Publicado: (2014)